Jessica Dehart
  • Email
    jessica.dehart@cgu.edu
  • Phone
    909-607-6001
  • CV
    Download (PDF)
  • Degrees
    PhD, Molecular Cancer Epidemiology, University of Texas, Houston
    MPH, Chronic Disease Epidemiology, Yale University
    BA, Health Promotion and Disease Prevention, University of Southern California
  • Research Interests
    Epidemiology, chronic disease, cancer etiology, cancer survivorship, molecular and genetic epidemiology, lifestyle intervention trials, exercise, nutrition, quality of life, community-based interventions

Jessica Clague DeHart is a molecular epidemiologist and assistant professor. Clague DeHart graduated from the University of Southern California with a bachelors in health promotion and disease prevention. She completed a masters of public health in chronic disease epidemiology from Yale University and a PhD in molecular cancer epidemiology from UT Houston and MD Anderson Cancer Center. Clague DeHart completed a postdoctoral fellowship at the City of Hope in the Division of Clinical Cancer Genetics where she investigated hereditary breast and ovarian in Hispanic populations. As an assistant professor at the City of Hope she developed a research program that uses data from large observational studies to design wellness intervention trials.

Clague DeHart is currently the principal investigator on several community-based intervention trials that investigate the impact of nutrition and exercise on molecular markers of cancer prevention, progression, and symptom management. A major focus of her research is the prevention and treatment of metabolic syndrome and obesity in cancer patients and survivors.

Co-authored with Timothy J. Williamson, et al. “Metastatic Breast Cancer Collateral Damage Project (MBCCD): Scale development and preliminary results of the Survey of Health, Impact, Needs, and Experiences (SHINE).” Breast Cancer Research 171, no. 1 (2018): 75-84. PMID: 29767345

Co-authored with Huiyan Ma, et al. “Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study.” Breast Cancer Research 18, no. 1 (2016): 62. PMCID: PMC4912767

Co-authored with Peggy Reynolds, et al. “Recent Menopausal Estrogen-Only Therapy Decreases Lung Cancer Mortality in Women Enrolled in the California Teachers Study.” PLoS ONE 9, no. 7 (2014): e103735.

Co-authored with Jeffrey N. Weitzel, et al. “Prevalence and Type of BRCA Mutations in Hispanics undergoing Genetic Cancer Risk Assessment in the Southwestern United States.” J Clin Oncol 31, no. 2 (2013): 210-216.

Co-authored with Leslie Bernstein. “Physical Activity and Cancer (Review).” Curr Oncol Rep 14, no. 6 (2012): 550-558.

Co-authored with Peggy Reynolds, et al. “Menopausal Hormone Therapy Does not Influence Lung Cancer Risk: Results from the California Teachers Study.” Cancer Epidemiol Biomarkers Prev 20, no. 3 (2011): 560-564. PMCID: PMC3065239 *Selected as a Member of the Faculty of 1000 (F1000).

Co-authored with Greg Wilhoite, et al. “RAD51C germline mutations in breast and ovarian cancer cases from high-risk families.” PLoS ONE 6, no. 9 (2011): e25632.